Ferdinand Otto

878 total citations
24 papers, 252 citations indexed

About

Ferdinand Otto is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Ferdinand Otto has authored 24 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 6 papers in Neurology. Recurrent topics in Ferdinand Otto's work include Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (4 papers) and Vector-borne infectious diseases (3 papers). Ferdinand Otto is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (4 papers) and Vector-borne infectious diseases (3 papers). Ferdinand Otto collaborates with scholars based in Austria, Germany and Switzerland. Ferdinand Otto's co-authors include Peter Wipfler, Georg Pilz, Andrea Harrer, Eugen Trinka, Johann Sellner, Tobias Moser, Johannes Sebastian Mutzenbach, Elisabeth Haschke‐Becher, Slaven Pikija and Wolfgang Hitzl and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Neuroinflammation and Cells.

In The Last Decade

Ferdinand Otto

20 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferdinand Otto Austria 11 57 53 46 38 35 24 252
Serpil Şener Türkiye 13 36 0.6× 13 0.2× 58 1.3× 27 0.7× 36 1.0× 45 354
Nabil Belfeki France 9 45 0.8× 56 1.1× 32 0.7× 22 0.6× 20 0.6× 49 220
K. Bouslama Tunisia 8 66 1.2× 117 2.2× 33 0.7× 50 1.3× 68 1.9× 45 357
Aurelia Sega Poland 7 34 0.6× 35 0.7× 12 0.3× 28 0.7× 18 0.5× 12 201
Hanns‐Martin Lorenz Germany 9 15 0.3× 68 1.3× 28 0.6× 76 2.0× 8 0.2× 19 278
Jeong Hun Bae South Korea 14 31 0.5× 44 0.8× 61 1.3× 22 0.6× 348 9.9× 43 500
Bengü Demirağ Türkiye 11 50 0.9× 43 0.8× 59 1.3× 12 0.3× 6 0.2× 49 327
S. Yu. Chikina Russia 8 155 2.7× 67 1.3× 17 0.4× 23 0.6× 16 0.5× 38 277
Behzad Amoozgar United States 10 17 0.3× 31 0.6× 34 0.7× 29 0.8× 186 5.3× 37 327
Mirosława Dubaniewicz-Wybieralska Poland 10 140 2.5× 52 1.0× 74 1.6× 26 0.7× 26 0.7× 27 388

Countries citing papers authored by Ferdinand Otto

Since Specialization
Citations

This map shows the geographic impact of Ferdinand Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinand Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinand Otto more than expected).

Fields of papers citing papers by Ferdinand Otto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdinand Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinand Otto. The network helps show where Ferdinand Otto may publish in the future.

Co-authorship network of co-authors of Ferdinand Otto

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdinand Otto. A scholar is included among the top collaborators of Ferdinand Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdinand Otto. Ferdinand Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrer, Andrea, Barbara A. Slade, Hannes Oberkofler, et al.. (2025). Selective S1P Receptor Modulation in Multiple Sclerosis Alters CXCL13:CXCR5-Associated Immune Activities Without Impacting Anti-SARS-CoV-2 Immunity. Neurology and Therapy. 14(6). 2583–2604.
2.
Otto, Ferdinand, et al.. (2024). Impact of Continuous Ofatumumab Exposure During Pregnancy in Multiple Sclerosis. Neurology Clinical Practice. 15(1). e200410–e200410.
3.
4.
Otto, Ferdinand, Lara Bieler, Tobias Moser, et al.. (2024). Beyond T cell toxicity – Intrathecal chemokine CXCL13 indicating B cell involvement in immune‐related adverse events following checkpoint inhibition: A two‐case series and literature review. European Journal of Neurology. 31(7). e16279–e16279. 7 indexed citations
5.
6.
Moser, Tobias, Ciara K. O’Sullivan, Ferdinand Otto, et al.. (2022). Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study. Therapeutic Advances in Neurological Disorders. 15. 4213373180–4213373180. 11 indexed citations
7.
Moser, Tobias, Ferdinand Otto, Ciara K. O’Sullivan, et al.. (2022). Recall response to COVID-19 antigen is preserved in people with multiple sclerosis on anti-CD20 medications – A pilot study. Multiple Sclerosis and Related Disorders. 59. 103560–103560. 9 indexed citations
8.
Otto, Ferdinand, et al.. (2022). The CXCL13/CXCR5 Immune Axis in Health and Disease—Implications for Intrathecal B Cell Activities in Neuroinflammation. Cells. 11(17). 2649–2649. 29 indexed citations
9.
Jones, Neil D., et al.. (2022). Tick-Borne Encephalitis Virus RNA Found in Frozen Goat’s Milk in a Family Outbreak. International Journal of Molecular Sciences. 23(19). 11632–11632. 5 indexed citations
10.
Otto, Ferdinand, Georg Pilz, Elisabeth Haschke‐Becher, et al.. (2021). The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF. Fluids and Barriers of the CNS. 18(1). 40–40. 21 indexed citations
11.
Otto, Ferdinand, et al.. (2021). Role and Relevance of Cerebrospinal Fluid Cells in Diagnostics and Research: State-of-the-Art and Underutilized Opportunities. Diagnostics. 12(1). 79–79. 9 indexed citations
12.
Otto, Ferdinand, et al.. (2020). Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype. Multiple Sclerosis and Related Disorders. 42. 102108–102108. 1 indexed citations
13.
Otto, Ferdinand, et al.. (2020). Non-convulsive status epilepticus with right arm apraxia: A case report. Epilepsy & Behavior Reports. 14. 100371–100371. 1 indexed citations
14.
Harrer, Andrea, et al.. (2020). Neurological complications associated with influenza in season 2017/18 in Austria- a retrospective single center study. Journal of Clinical Virology. 127. 104340–104340. 10 indexed citations
15.
Pilz, Georg, Peter Wipfler, Ferdinand Otto, et al.. (2019). Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study. Journal of Neuroinflammation. 16(1). 13–13. 12 indexed citations
16.
Pilz, Georg, Peter Wipfler, Ferdinand Otto, et al.. (2019). Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases. Journal of Neuroimmunology. 338. 577087–577087. 11 indexed citations
17.
Mutzenbach, Johannes Sebastian, et al.. (2017). Acute treatment of stroke due to spontaneous calcified cerebral emboli causing large vessel occlusion. Journal of Clinical Neuroscience. 47. 56–61. 16 indexed citations
18.
Otto, Ferdinand, et al.. (2016). Causes of death in critically ill multiple sclerosis patients. Acta Neurologica Scandinavica. 136(4). 305–309. 3 indexed citations
19.
Mutzenbach, Johannes Sebastian, et al.. (2016). Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab – a case report. Annals of Clinical and Translational Neurology. 3(11). 889–892. 27 indexed citations
20.
Scharitzer, Martina, Peter Pokieser, Michaela Wagner‐Menghin, Ferdinand Otto, & Olle Ekberg. (2016). Taking the history in patients with swallowing disorders: an international multidisciplinary survey. Abdominal Radiology. 42(3). 786–793. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Serpil Şener Breakdown of academic impact, for papers by Nabil Belfeki Breakdown of academic impact, for papers by K. Bouslama Breakdown of academic impact, for papers by Aurelia Sega Breakdown of academic impact, for papers by Hanns‐Martin Lorenz Breakdown of academic impact, for papers by Jeong Hun Bae Breakdown of academic impact, for papers by Bengü Demirağ Breakdown of academic impact, for papers by S. Yu. Chikina Breakdown of academic impact, for papers by Behzad Amoozgar Breakdown of academic impact, for papers by Mirosława Dubaniewicz-Wybieralska
Rankless by CCL
2026